Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Loo, H.
Poirier-Littre, M.-F.
Theron, M.
Rein, W.
and
Fleurot, O.
1997.
Amisulpride versus placebo in the medium-term treatment of the negative symptoms of schizophrenia.
British Journal of Psychiatry,
Vol. 170,
Issue. 1,
p.
18.
Schmauß, M.
1999.
Atypische Neuroleptika.
p.
57.
Balestrieri, Matteo
Vampini, Claudio
and
Bellantuono, Cesario
2000.
Efficacy and safety of novel antipsychotics: a critical review.
Human Psychopharmacology: Clinical and Experimental,
Vol. 15,
Issue. 7,
p.
499.
Silveira da Mota Neto, Joaquim I
Soares, Bernardo GO
and
Silva de Lima, Mauricio
2002.
Amisulpride for schizophrenia.
Cochrane Database of Systematic Reviews,
Vol. 2013,
Issue. 1,
Linden, Michael
Scheel, Tabea
and
Xaver Eich, Franz
2004.
Dosage finding and outcome in the treatment of schizophrenic inpatients with amisulpride. Results of a drug utilization observation study.
Human Psychopharmacology: Clinical and Experimental,
Vol. 19,
Issue. 2,
p.
111.
Barrett, S. L.
Bell, R.
Watson, D.
and
King, D. J.
2004.
Effects of Amisulpride, Risperidone and Chlorpromazine on Auditory and Visual Latent Inhibition, Prepulse Inhibition, Executive Function and Eye Movements in Healthy Volunteers.
Journal of Psychopharmacology,
Vol. 18,
Issue. 2,
p.
156.
Comments
No Comments have been published for this article.